BioAtla, Inc. (BCAB)
NASDAQ·Healthcare·Biotechnology
$4.47
-0.94%
Mkt Cap $5.31M
Next Earnings
In 14 daysTue, May 12, 2026
EPS Estimate
-$10.00
1 analysts
Revenue Estimate
$1.72M
Last quarter: beat by +33.33% on EPS, +185.71% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$5.31M
P/E
—
Fwd P/E
—
P/S
5.55
Rev TTM
—
EPS TTM
-$50.50